Category: Providers

340B Lobbying Still on Track for Record Year

November 2, 2023 Rich Daly, Editor in Chief Views

Darbin Wofford, a health policy advisor at Third Way, said his organization is urging Congressional Democrats to adopt 340B program reforms.

Lobbying on 340B issues in 2023 remains on track for a record-breaking year, according to recently released congressional lobbying reports. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

New York State Asks Court to Dismiss Challenge to Medicaid Drug Benefit Shift

November 2, 2023 Tom Mirga, Editor at Large Views

The New York State Department of Health asked a state trial court to dismiss two providers' challenge to a Medicaid drug benefit shift.

The New York State Department of Health recently told a state trial court in Manhattan that two community health centers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Program May Lead to Lower Charity Care, Says Drug Industry-Backed AIDS Group

November 2, 2023 William Newton, Associate Editor/Senior Writer Views

Brandon Macsata, CEO of ADAP Advocacy, said the group plans to publish data from its ongoing study on the 340B program later this year.

Enrollment in the 340B program was linked to diminished spending on charity care, according to preliminary findings from an ongoing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sandoz Is 28th Drugmaker to Adopt 340B Contract Pharmacy Restrictions

November 1, 2023 Tom Mirga, Editor at Large Views

Drugmaker Sandoz, a Novartis spin-off, became the 28th pharmaceutical company to implement 340B contract pharmacy restrictions.

Generic and biosimilar drugmaker Sandoz today became the 28th pharmaceutical company to place conditions on 340B pricing involving drug shipments [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

October 31, 2023 William Newton, Associate Editor/Senior Writer Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Hospital Registration Waiver Withdrawal Could Draw Legal Challenge

October 31, 2023 Tom Mirga, Editor at Large Views

Dept. of Health and Human Services building and signage

Hospital advocates said HRSA's recent decision to end a 340B program waiver for hospitals could draw legal challenges.

The recent end of a 340B program waiver for hospitals is wrong, hurts hospitals and their patients, and is bound [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Hospitals’ Community Benefit Surges in 2020, Says Hospital-Backed Report

October 31, 2023 Rich Daly, Editor in Chief Views

The American Hospital Association published a study that found 340B hospitals' community benefit increased significantly in 2020.

The community benefits provided by 340B hospitals surged by $16.5 billion, or 24%, in the latest year analyzed by a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA To End Waiver for Some Offsite 340B Hospital Locations, Provides Grace Period

October 26, 2023 Tom Mirga, Editor at Large Views

HRSA confirmed it will end a pandemic-era waiver program that allowed 340B drug use in certain offsite hospital locations.

The Health Resources and Services Administration (HRSA) confirmed today it is ending a 340B program waiver issued early in the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Provider-Genentech Lobbying Group Boosts Spending, Adds Members

October 26, 2023 Tom Mirga, Editor at Large Views

More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.

Genentech, Sanford Health, and Carolina Health Centers’ 340B reform group, 340B Working Table, spent $110,000 on lobbying and gained eight [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Adds Drug to Contract Pharmacy Restriction List

October 26, 2023 Rich Daly, Editor in Chief Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

GlaxoSmithKline (GSK) recently restricted 340B pricing on Jesduvroq, an anemia treatment, when providers dispense it through contract pharmacies. GSK contractor [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Providers

340B Lobbying Still on Track for Record Year

Please Login or Become a Paid Subscriber to View this Content

If you are already a

New York State Asks Court to Dismiss Challenge to Medicaid Drug Benefit Shift

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Program May Lead to Lower Charity Care, Says Drug Industry-Backed AIDS Group

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Sandoz Is 28th Drugmaker to Adopt 340B Contract Pharmacy Restrictions

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Hospital Registration Waiver Withdrawal Could Draw Legal Challenge

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Hospitals’ Community Benefit Surges in 2020, Says Hospital-Backed Report

Please Login or Become a Paid Subscriber to View this Content

If you are already a

HRSA To End Waiver for Some Offsite 340B Hospital Locations, Provides Grace Period

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Provider-Genentech Lobbying Group Boosts Spending, Adds Members

Please Login or Become a Paid Subscriber to View this Content

If you are already a

GSK Adds Drug to Contract Pharmacy Restriction List

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live